The Underlying Thrombotic Risk in Patients with Atherosclerotic Vascular Disease
Coronary artery disease (CAD) and peripheral artery disease (PAD) are clinical manifestations of vascular disease, sharing common pathophysiologic characteristics of atherosclerosis and atherothrombosis. Both are associated with a persistent underlying thrombotic risk of recurrent major adverse cardiovascular events (MACE), which can confer significant morbidity and mortality. This presentation will discuss the prevalence, epidemiology, risk factors, and the residual risk of cardiovascular events, that exist in spite of current guidelines-based treatment recommendations in managing these patient populations.
Consultant is a paid speaker for Janssen Pharmaceuticals, Inc.